Abstract
The aim of this study was to evaluate skeletal pain associated with osteoporosis and to examine the inhibitory effect of bisphosphonate (BP) on pain in an ovariectomized (OVX) mouse model. We evaluated skeletal pain in OVX mice through an examination of pain-like behavior as well as immunohistochemical findings. In addition, we assessed the effects of alendronate (ALN), a potent osteoclast inhibitor, on those parameters. The OVX mice showed a decrease in the pain threshold value, and an increase in the number of c-Fos immunoreactive neurons in laminae I–II of the dorsal horn of the spinal cord. Alendronate caused an increase in the pain threshold value and inhibited c-Fos expression. The serum level of tartrate-resistant acid phosphatase 5b, a marker of osteoclast activity, was significantly negatively correlated with the pain threshold value. Furthermore, we found that an antagonist of the transient receptor potential channel vanilloid subfamily member 1, which is an acid-sensing nociceptor, improved pain-like behavior in OVX mice. These results indicated that the inhibitory effect of BP on osteoclast function might contribute to an improvement in skeletal pain in osteoporosis patients.
Similar content being viewed by others
References
Gass M, Dawson HB (2006) Preventing osteoporosis-related fractures: an overview. Am J Med 119:S3–S11
National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
Kann P, Schulz G, Schehler B, Beyer J (1993) Backache and osteoporosis in perimenopausal women. Med Klin 88:9–15
Iwamoto J, Takeda T, Sato Y, Uzawa M (2004) Effect of alendronate on metacarpal and lumbar bone mineral density, bone resorption and chronic back pain in postmenopausal women with osteoporosis. Clin Rheumatol 23:383–389
Ghinoi V, Brandi ML (2002) Clodronate: mechanisms of action on bone remodeling and clinical use in osteometabolic disorders. Expert Opin Pharmacother 3:1643–1656
Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ (2001) Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28:465–473
Ohtori S, Akazawa T, Murata Y, Kinoshita T, Yamashita M, Nakagawa K, Inoue G, Nakamura J, Orita S, Ochiai N, Kishida S, Takasa M, Eguchi Y, Yamauchi K, Suzuki M, Aoki Y, Takahashi K (2010) Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures. J Clin Neurosci 17:209–213
Bonabello A, Galmozzia MR, Bruzzesea T, Zara GP (2001) Analgesic effect of bisphosphonates in mice. Pain 91:269–275
Carvalho AP, Bezerra MM, Girao VC, Cunha FQ, Rocha FA (2006) Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain model in rats and mice. Clin Exp Pharmacol Physiol 33:601–606
Nagae M, Hiraga T, Wakabayashi H, Wang L, Iwata K, Yoneda T (2006) Osteoclasts play a part in pain due to the inflammation adjacent to bone. Bone 39:1107–1115
Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C (1998) The role of bisphosphonates in the treatment of painful metastatic bone disease. Pain 78:157–169
Iba K, Takada J, Wada T, Yamashita T (2010) Five-year follow-up of Japanese patients with Paget’s disease of the bone after treatment with low-dose oral alendronate: a case series. J Med Case Rep 4:166
Astrom E, Soderhall S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfect. Arch Dis Child 86:356–364
Washimi Y, Chen H, Ito A, Takao R, Uzawa T, Yamamoto Y, Yamada H, Shoumura S (2010) Effect of intermittent treatment with human parathyroid hormone 1–34 in SAMP6 senescence-accelerated mice. J Endocrinol Invest 33:395–400
Wang X, Wu J, Chiba H, Umegaki K, Yamada K, Ishimi Y (2003) Puerariae radix prevents bone loss in ovariectomized mice. J Bone Miner Metab 21:268–275
Wright LE, Christian PJ, Rivera Z, Van Alstine WG, Funk JL, Bouxsein ML, Hoyer PB (2008) Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice. J Bone Miner Res 23:1296–1303
Furuya Y, Mori K, Ninomiya T, Tomimori Y, Tanaka S, Takahashi N, Udagawa N, Uchida K, Yasuda H (2011) Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-κB ligand-neutralizing antibody. J Biol Chem 286:37023–37031
Kawamata T, Ji W, Yamamoto J, Niiyama Y, Furuse S, Namiki A (2008) Contribution of transient receptor vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia. Neuroscience 15:1067–1076
Luger NM, Sabino MA, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW (2002) Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain. Pain 99:397–406
Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835:18–26
Shoji S, Tabuchi M, Miyazawa K, Yabumoto T, Tanaka M, Kadota M, Maeda H, Goto S (2010) Bisphosphonate inhibits bone turnover in OPG−/−mice via a depressive effect on both osteoclasts and osteoblasts. Calcif Tissue Int 87:181–192
Niiyama Y, Kawamata T, Yamamoto J, Furuse S, Namiki A (2009) SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Br J Anaesth 102:251–258
Kawamata T, Ji W, Yamamoto J, Niiyama Y, Furuse S, Omote K, Namiki A (2009) Involvement of transient receptor potential vanilloid subfamily 1 in endthelin-1-induced pain-like behavior. Neuroreport 20:233–237
Oda K, Amaya Y, Fukushi-Irie M, Kinameri Y, Ohsuye K, Kubota I, Fujimura S, Kobayashi J (1999) A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase. J Biochem 126:694–699
Kojima T, Freitas PH, Ubaidus S, Suzuki A, Li M, Yoshizawa M, Oda K, Maeda T, Kudo A, Saito C, Amizuka N (2007) Histochemical examinations on cortical bone regeneration induced by thermoplastic bioresorbable plates applied to bone defects of rat calvariae. Biomed Res 28:219–229
Laitala-Leinonen T, Lowik C, Papapoulous S, Vaananen HK (1999) Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro. J Cell Sci 112:3657–3666
Cummings SR, Melton LJ (2002) Osteoporosis I: epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767
Hamba M, Muro M, Hiraide T, Ozawa H (1994) Expression of c-fos like protein of in the rat brain after injection of interleukin-1-beta into the gingiva. Brain Res Bull 34:61–68
Takayama B, Kikuchi S, Konno S, Sekiguchi M (2008) An immunohistochemical study of the antinociceptive effects of calcitonin in ovariectomized rats. BMC Muscloskelet Disord 9:164
Hunt SP, Pini A, Evan G (1987) Induction of c-fos like protein in spinal cord neurons following sensory stimulation. Nature 328:632–634
Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504–1508
Rousselle AV, Heymann D (2002) Osteoclastic acidification pathways during bone resorption. Bone 30:533–540
Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203–210
Mantyh PW, Clohisy DR, Koltzenburg M, Hunt SP et al (2002) Molecular mechanisms of cancer pain. Nat Rev Cancer 2:201–209
Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O’Leary P, Mantyh PW (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113:155–166
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824
Nagae M, Hiraga T, Yoneda T (2007) Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization. J Bone Miner Metab 25:99–104
Varga A, Nemeth J, Szabo A, McDougall JJ, Zhang C, Elekes K, Pinter E, Szolcsanyi J, Helyes Z (2005) Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett 385:137–142
Akesson K (2003) New approaches to pharmacological treatment of osteoporosis. Bull World Health Organ 81:657–664
Sanoja R, Cervero F (2010) Estrogen-dependent changes in visceral afferent sensitivity. Auton Neurosci 153:84–89
Sanoja R, Cervero F (2005) Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: a model of functional abdominal pain. Pain 118:243–253
Orita S, Ohtori S, Koshi T, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Eguchi Y, Kamoda H, Arai G, Ishikawa T, Miyagi M, Ochiai N, Kishida S, Takaso M, Aoki Y, Toyone T, Takahashi K (2010) The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervations. Spine 35:1974–1982
Van Offel JF, Schuerwegh AJ, Bridts CH, Bracke PG, Stevens WJ, De Clerck LS (2001) Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol 19:13–20
Le Goff B, Heymann D (2011) Pharmacodynamics of bisphosphonates in arthritis. Expert Rev Clin Pharmacol 4:633–641
Roelofs AJ, Coxon FP, Ebetino FH, Lundy MW, Henneman ZJ, Nancollas GH, Sun S, Blazewska KM, Bala JL, Kashemirov BA, Khalid AB, Mckenna CE, Rogers MJ (2010) Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. J Bone Miner Res 25:606–616
Ringe JD, Body JJ (2007) A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover. Clin Exp Rheumatol 25:766–774
Acknowledgments
We would like to thank Prof. Moriyama, Department of Membrane Biochemistry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan, for kindly providing the antibody to V-ATPase. This study was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, and by a grant for scientific research from MSD K.K. (Tokyo, Japan).
Conflict of interest
All authors have no potential conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Abe, Y., Iba, K., Sasaki, K. et al. Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice. J Bone Miner Metab 33, 125–134 (2015). https://doi.org/10.1007/s00774-014-0574-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-014-0574-x